Related Experiment Video
Updated: Jun 4, 2026
06:51
Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
MicroRNAs in Parkinson's disease.
Maged M Harraz1, Ted M Dawson, Valina L Dawson
1Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Journal of Chemical Neuroanatomy
|February 8, 2011
Summary
MicroRNAs regulate gene expression and are crucial in nervous system function. This review explores the link between microRNA pathways and Parkinson's disease, highlighting therapeutic potential.
Area of Science:
- Molecular Biology
- Neuroscience
- Genetics
Background:
- MicroRNAs (miRNAs) are small, non-coding RNAs regulating gene expression post-transcriptionally.
- miRNAs play vital roles in nervous system development, function, and disease pathogenesis.
- Parkinson's disease (PD) is a prevalent neurodegenerative disorder with limited symptomatic treatments.
Purpose of the Study:
- To review the current understanding of microRNA involvement in Parkinson's disease.
- To highlight the potential of targeting microRNA pathways for PD therapeutics.
Main Methods:
- Literature review of recent studies on microRNAs and Parkinson's disease.
- Analysis of research linking miRNA pathways to PD mechanisms and progression.
Main Results:
- Emerging evidence implicates specific microRNAs in the molecular pathways dysregulated in Parkinson's disease.
- The microRNA pathway represents a promising area for novel therapeutic strategies in PD.
Conclusions:
- MicroRNAs are significantly involved in the pathogenesis of Parkinson's disease.
- Targeting microRNAs offers a potential new avenue for Parkinson's disease treatment development.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...